Autobio Financial Statements From 2010 to 2025

Stocks . China . 
Stock . Autobio Diagnostics Co
603658 Stock   40.09  0.11  0.27%   
Autobio Diagnostics financial statements provide useful quarterly and yearly information to potential Autobio Diagnostics Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Autobio Diagnostics financial statements helps investors assess Autobio Diagnostics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Autobio Diagnostics' valuation are summarized below:
Gross Profit
3 B
Profit Margin
0.2778
Market Capitalization
23.3 B
Enterprise Value Revenue
5.0293
Revenue
4.6 B
We have found seventy-seven available fundamental signals for Autobio Diagnostics Co, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Autobio Diagnostics Co prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road.

Autobio Diagnostics Total Revenue

5.37 Billion

Check Autobio Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Autobio Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 29.6 M, Selling General Administrative of 373.1 M or Total Revenue of 5.4 B, as well as many indicators such as . Autobio financial statements analysis is a perfect complement when working with Autobio Diagnostics Valuation or Volatility modules.
  
This module can also supplement various Autobio Diagnostics Technical models . Check out the analysis of Autobio Diagnostics Correlation against competitors.

Autobio Diagnostics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets14 B13.3 B5 B
Slightly volatile
Other Current Liabilities99.2 M104.4 M212.5 M
Slightly volatile
Total Current Liabilities3 B2.9 B985.2 M
Slightly volatile
Total Stockholder Equity10.3 B9.8 B3.8 B
Slightly volatile
Other Liabilities455.3 M433.6 M163.6 M
Slightly volatile
Retained Earnings4.6 B4.4 B1.6 B
Slightly volatile
Accounts Payable876.8 M835.1 M293.8 M
Slightly volatile
Cash1.8 B1.7 B496.4 M
Slightly volatile
Other Assets657.2 M625.9 M216.5 M
Slightly volatile
Net Receivables1.4 B1.3 B547.9 M
Slightly volatile
Good Will98.1 M189.3 M90.4 M
Slightly volatile
Inventory939.8 M895 M354.1 M
Slightly volatile
Other Current Assets2.9 B2.7 B552.3 M
Slightly volatile
Total Liabilities3.5 B3.3 B1.2 B
Slightly volatile
Intangible Assets141.4 M205.9 M126.3 M
Slightly volatile
Common Stock383 M674.2 M365.1 M
Slightly volatile
Property Plant Equipment4 B3.8 B1.5 B
Slightly volatile
Long Term Debt607.4 M578.5 M252.4 M
Slightly volatile
Net Tangible Assets9 B8.5 B3.5 B
Slightly volatile
Deferred Long Term Liabilities205.2 M195.5 M70.1 M
Slightly volatile
Non Current Assets Total3 B5.7 B2.1 B
Slightly volatile
Non Currrent Assets Other416.1 M232.6 M543 M
Slightly volatile
Short Term Investments662 M630.5 M552.9 M
Slightly volatile
Non Current Liabilities Total313.1 M465.2 M201.5 M
Slightly volatile
Total Current Assets4 B7.6 B3 B
Slightly volatile
Net Debt794.5 M756.7 M308.6 M
Slightly volatile
Common Stock Shares Outstanding625.9 M674.2 M569.1 M
Slightly volatile
Net Invested Capital6 B10.2 B4.1 B
Slightly volatile
Short and Long Term Debt414.5 M394.8 M118.7 M
Slightly volatile
Non Current Liabilities Other109.8 M104.5 M48.1 M
Slightly volatile
Net Working Capital2.9 B4.7 B1.8 B
Slightly volatile
Short Term Debt54.7 M52.1 M24.2 M
Slightly volatile
Capital Stock559.1 M674.2 M477.7 M
Slightly volatile
Property Plant And Equipment Net3 B4.5 B2.2 B
Slightly volatile
Property Plant And Equipment Gross3.9 B6.3 B2.9 B
Slightly volatile
Capital Lease Obligations23.7 M28.3 M20.5 M
Slightly volatile

Autobio Diagnostics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative373.1 M427.2 M330.7 M
Slightly volatile
Total Revenue5.4 B5.1 B2.2 B
Slightly volatile
Operating Income1.6 B1.5 B675.5 M
Slightly volatile
Research Development792.3 M754.5 M288 M
Slightly volatile
Cost Of Revenue1.9 B1.8 B782.9 M
Slightly volatile
Income Before Tax1.6 B1.6 B700.8 M
Slightly volatile
Income Tax Expense65.2 M120.8 M63.3 M
Slightly volatile
Other Operating Expenses21.8 M31.7 M18 M
Slightly volatile
Net Income Applicable To Common Shares728.7 M1.3 B620.6 M
Slightly volatile
Tax Provision98.8 M159.2 M82.8 M
Slightly volatile
Interest Income18.6 M17.7 M7.9 M
Slightly volatile
Gross Profit2 B3.3 B1.5 B
Slightly volatile
Net Income From Continuing Ops867.8 M1.4 B667.8 M
Slightly volatile
EBIT836.3 M1.3 B717.2 M
Slightly volatile
Total Operating Expenses2.2 B3.6 B1.6 B
Slightly volatile
Net Income857.9 M1.4 B662.2 M
Slightly volatile
EBITDA1.3 B2 B1 B
Slightly volatile
Reconciled Depreciation327.6 M519.3 M235.4 M
Slightly volatile

Autobio Diagnostics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures544.3 M1 B503.5 M
Slightly volatile
Total Cash From Operating Activities1.8 B1.7 B761.4 M
Slightly volatile
Other Cashflows From Investing Activities148.1 M141 M50.5 M
Slightly volatile
Change To Liabilities216.7 M213.7 M145.5 M
Slightly volatile
Depreciation296.8 M519.3 M213.5 M
Slightly volatile
Net Income857.9 M1.4 B662.2 M
Slightly volatile
End Period Cash Flow1.8 B1.7 B489.6 M
Slightly volatile
Begin Period Cash Flow1.4 B1.3 B348.9 M
Slightly volatile
Other Non Cash Items38.7 M61.2 M24.6 M
Slightly volatile

About Autobio Diagnostics Financial Statements

Autobio Diagnostics stakeholders use historical fundamental indicators, such as Autobio Diagnostics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Autobio Diagnostics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Autobio Diagnostics' assets and liabilities are reflected in the revenues and expenses on Autobio Diagnostics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Autobio Diagnostics Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue5.1 B5.4 B
Cost Of Revenue1.8 B1.9 B

Currently Active Assets on Macroaxis

EBRCentrais Electricas Brasileiras
HEHawaiian Electric Industries
VFCVF Corporation
BVHMFVistry Group PLC
SSentinelOne

Other Information on Investing in Autobio Stock

Autobio Diagnostics financial ratios help investors to determine whether Autobio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Autobio with respect to the benefits of owning Autobio Diagnostics security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY